We are live on ! Find out more
APTX

Aptinyx Inc. Common Stock

Delisted

APTX was delisted on the 18th of May, 2023.

60 hedge funds and large institutions have $81.3M invested in Aptinyx Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

110% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $581K

22% more funds holding

Funds holding: 4960 (+11)

15% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 13

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

12% less capital invested

Capital invested by funds: $92.4M → $81.3M (-$11.1M)

Holders
60
Holders Change
+11
Holders Change %
+22.45%
% of All Funds
0.95%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
15
Reduced
13
Closed
1
Calls
$1.22M
Puts
$581K
Net Calls
+$638K
Net Calls Change
+$594K
Name Holding Trade Value Shares
Change
Change in
Stake
BCLSI
1
Bain Capital Life Sciences Investors
Massachusetts
$20.2M
AG
2
Artal Group
Luxembourg
$13.9M
ASP
3
Adams Street Partners
Illinois
$12.2M
NLVP
4
New Leaf Venture Partners
New York
$7.47M
Vanguard Group
5
Vanguard Group
Pennsylvania
$4.46M +$458K +152,943 +8%
FLSM
6
Frazier Life Sciences Management
California
$4.28M +$5.64M +1,883,244 New
BlackRock
7
BlackRock
New York
$2.99M -$176K -58,851 -4%
Millennium Management
8
Millennium Management
New York
$2.98M +$201K +67,131 +5%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$2.53M +$2.84M +947,396 +565%
O
10
OrbiMed
New York
$1.22M -$632K -211,000 -28%
AC
11
AWH Capital
Texas
$1.11M -$555K -185,144 -27%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$858K +$24.9K +8,320 +2%
JP Morgan Chase
13
JP Morgan Chase
New York
$600K
Renaissance Technologies
14
Renaissance Technologies
New York
$597K -$300 -100 -0%
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$505K -$63K -21,005 -9%
Northern Trust
16
Northern Trust
Illinois
$498K +$442K +147,357 +204%
BCM
17
Bridgeway Capital Management
Texas
$471K -$150K -50,000 -19%
MWM
18
Meridian Wealth Management
Kentucky
$436K
Two Sigma Advisers
19
Two Sigma Advisers
New York
$379K -$101K -33,700 -17%
Dimensional Fund Advisors
20
Dimensional Fund Advisors
Texas
$320K +$50.3K +16,774 +14%
Victory Capital Management
21
Victory Capital Management
Texas
$319K +$421K +140,360 New
State Street
22
State Street
Massachusetts
$314K +$26.2K +8,749 +7%
NU
23
Northwestern University
Illinois
$248K
Simplex Trading
24
Simplex Trading
Illinois
$239K +$317K +105,717 New
RJA
25
Raymond James & Associates
Florida
$206K +$1.44K +480 +0.5%

APTX Hedge Fund Activity: Q1 2022 in Review

60 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Aptinyx Inc. Common Stock (APTX) for Q1 2022, worth a combined $81.3M — down 12% from $92.4M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new APTX positions and 1 closed out — a net gain of 11 holders — while 15 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $2.84M. The largest seller was Frazier Management, exiting entirely with an estimated $5.03M sold.

  • 60 institutional investors held Aptinyx Inc. Common Stock (APTX) as of Q1 2022, up from 49 in Q4 2021.
  • Funds reported $81.3M of Aptinyx Inc. Common Stock stock for Q1 2022, down 12% quarter-over-quarter.
  • 12 funds opened new Aptinyx Inc. Common Stock positions in Q1 2022 and 1 closed out, a net change of +11 holders.
  • The largest Aptinyx Inc. Common Stock buyer in Q1 2022 was Point72 Asset Management, an estimated $2.84M added.
  • The largest Aptinyx Inc. Common Stock seller in Q1 2022 was Frazier Management, an estimated $5.03M sold.

Based on aggregated 13F filings for Q1 2022.